Literature DB >> 11909790

Cancer chemoprevention.

Peter Greenwald1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11909790      PMCID: PMC1122644          DOI: 10.1136/bmj.324.7339.714

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  22 in total

Review 1.  Perspectives on cancer chemoprevention research and drug development.

Authors:  G J Kelloff
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

2.  Diallyl disulfide inhibits p34(cdc2) kinase activity through changes in complex formation and phosphorylation.

Authors:  L M Knowles; J A Milner
Journal:  Carcinogenesis       Date:  2000-06       Impact factor: 4.944

Review 3.  Cancer chemoprevention: progress and promise.

Authors:  G J Kelloff; C C Sigman; P Greenwald
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

4.  Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.

Authors:  O Kucuk; F H Sarkar; W Sakr; Z Djuric; M N Pollak; F Khachik; Y W Li; M Banerjee; D Grignon; J S Bertram; J D Crissman; E J Pontes; D P Wood
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-08       Impact factor: 4.254

5.  Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide.

Authors:  E Singletary; R Lieberman; N Atkinson; N Sneige; A Sahin; S Tolley; M Colchin; T Bevers; C Stelling; B Fornage; H Fritsche; W Hittelman; G Kelloff; S M Lippman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-10       Impact factor: 4.254

Review 6.  Prostate cancer prevention trials in the USA.

Authors:  O W Brawley; H Parnes
Journal:  Eur J Cancer       Date:  2000-06       Impact factor: 9.162

Review 7.  Diet and cancer prevention.

Authors:  P Greenwald; C K Clifford; J A Milner
Journal:  Eur J Cancer       Date:  2001-05       Impact factor: 9.162

Review 8.  Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.

Authors:  G J Kelloff; C C Sigman; K M Johnson; C W Boone; P Greenwald; J A Crowell; E T Hawk; L A Doody
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-02       Impact factor: 4.254

Review 9.  Prevention of cancer in the next millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research.

Authors: 
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

10.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.

Authors: 
Journal:  N Engl J Med       Date:  1994-04-14       Impact factor: 91.245

View more
  20 in total

Review 1.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract.

Authors:  Zong-Fang Li; Zhi-Dong Wang; Yuan-Yuan Ji; Shu Zhang; Chen Huang; Jun Li; Xian-Ming Xia
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

3.  Drugs for preventing lung cancer in healthy people.

Authors:  Marcela Cortés-Jofré; José-Ramón Rueda; Claudia Asenjo-Lobos; Eva Madrid; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04

4.  Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nanotechnology-based combined treatment system.

Authors:  Abhishek Chaudhary; Dhruvitkumar Sutaria; Ying Huang; Jeffrey Wang; Sunil Prabhu
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-13

Review 5.  Nutrition and head and neck cancer.

Authors:  Carl H Snyderman
Journal:  Curr Oncol Rep       Date:  2003-03       Impact factor: 5.075

6.  Interactions of the major metabolite of the cancer chemopreventive drug oltipraz with cytochrome c: a novel pathway for cancer chemoprevention.

Authors:  Murugesan Velayutham; Rajendra B Muthukumaran; Joe Z Sostaric; John McCraken; James C Fishbein; Jay L Zweier
Journal:  Free Radic Biol Med       Date:  2007-07-06       Impact factor: 7.376

7.  Identification of glutathione sulfotransferase-pi (GSTP1) as a new resveratrol targeting protein (RTP) and studies of resveratrol-responsive protein changes by resveratrol affinity chromatography.

Authors:  Tze-Chen Hsieh; Zhirong Wang; Haiteng Deng; Joseph M Wu
Journal:  Anticancer Res       Date:  2008 Jan-Feb       Impact factor: 2.480

Review 8.  Chemoprevention of melanoma.

Authors:  Marie-France Demierre; Glenn Merlino
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

Review 9.  Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Stefanos Bonovas; Gionata Fiorino; Theodore Lytras; Alberto Malesci; Silvio Danese
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

Review 10.  Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development.

Authors:  Stephen S Yoo; Timothy J Jorgensen; Ann R Kennedy; John D Boice; Alla Shapiro; Tom C-C Hu; Brian R Moyer; Marcy B Grace; Gary J Kelloff; Michael Fenech; Pataje G S Prasanna; C Norman Coleman
Journal:  J Radiol Prot       Date:  2014-04-14       Impact factor: 1.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.